Analystreport

Sutro Biopharma, Inc. (NASDAQ: STRO) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.

Sutro Biopharma, Inc.  (STRO) 
Last sutro biopharma, inc. earnings: 11/8 07:00 am Check Earnings Report